279 related articles for article (PubMed ID: 19059061)
21. Optimal dosing of warfarin and other coumarin anticoagulants: the role of genetic polymorphisms.
Daly AK
Arch Toxicol; 2013 Mar; 87(3):407-20. PubMed ID: 23376975
[TBL] [Abstract][Full Text] [Related]
22. An analysis of the relative effects of VKORC1 and CYP2C9 variants on anticoagulation related outcomes in warfarin-treated patients.
Meckley LM; Wittkowsky AK; Rieder MJ; Rettie AE; Veenstra DL
Thromb Haemost; 2008 Aug; 100(2):229-39. PubMed ID: 18690342
[TBL] [Abstract][Full Text] [Related]
23. Using pharmacogenetics in real time to guide warfarin initiation: a clinician update.
Carlquist JF; Anderson JL
Circulation; 2011 Dec; 124(23):2554-9. PubMed ID: 22144632
[No Abstract] [Full Text] [Related]
24. Interactive modeling for ongoing utility of pharmacogenetic diagnostic testing: application for warfarin therapy.
Linder MW; Bon Homme M; Reynolds KK; Gage BF; Eby C; Silvestrov N; Valdes R
Clin Chem; 2009 Oct; 55(10):1861-8. PubMed ID: 19679631
[TBL] [Abstract][Full Text] [Related]
25. Dosing anticoagulant therapy with coumarin drugs: is genotyping clinically useful? No.
Mannucci PM; Spreafico M; Peyvandi F
J Thromb Haemost; 2008 Sep; 6(9):1450-2. PubMed ID: 18627441
[No Abstract] [Full Text] [Related]
26. [Warfarin resistance and related pharmacogenetic information].
Takahashi H
Brain Nerve; 2008 Nov; 60(11):1365-71. PubMed ID: 19069171
[TBL] [Abstract][Full Text] [Related]
27. Is a "pharmacogenomic algorithm" helpful for adjusting the initial dose of warfarin in patients to be treated by warfarin therapy?
Goto S
Circ J; 2010 May; 74(5):850-1. PubMed ID: 20424335
[No Abstract] [Full Text] [Related]
28. [Pharmacogenetics of indirect anticoagulants: value of genotype for improvement of efficacy and safety of therapy].
Sychov DA; Kropacheva ES; Ignat'ev IV; Bulytova IuM; Dobrovol'skiĭ AB; Panchenko EP; Kukes VG
Kardiologiia; 2006; 46(7):72-7. PubMed ID: 16883270
[TBL] [Abstract][Full Text] [Related]
29. Validation of pharmacogenetic algorithms and warfarin dosing table in Egyptian patients.
Bazan NS; Sabry NA; Rizk A; Mokhtar S; Badary O
Int J Clin Pharm; 2012 Dec; 34(6):837-44. PubMed ID: 22851439
[TBL] [Abstract][Full Text] [Related]
30. Warfarin pharmacogenomics in children.
Vear SI; Stein CM; Ho RH
Pediatr Blood Cancer; 2013 Sep; 60(9):1402-7. PubMed ID: 23682017
[TBL] [Abstract][Full Text] [Related]
31. Genotype and adverse drug reactions to warfarin.
Byron KA; Dear AE
Med J Aust; 2007 Jul; 187(1):61-2. PubMed ID: 17605718
[No Abstract] [Full Text] [Related]
32. 10 years of oral anticoagulant pharmacogenomics: what difference will it make? A critical appraisal.
Kurnik D; Loebstein R; Halkin H; Gak E; Almog S
Pharmacogenomics; 2009 Dec; 10(12):1955-65. PubMed ID: 19958094
[TBL] [Abstract][Full Text] [Related]
33. Genetic determinants of dose and clinical outcomes in patients receiving oral anticoagulants.
Schwarz UI; Stein CM
Clin Pharmacol Ther; 2006 Jul; 80(1):7-12. PubMed ID: 16815312
[No Abstract] [Full Text] [Related]
34. Anticoagulant therapy: warfarin sensitivity genotyping closer to clinical practice.
van der Zee SA; Halperin JL
Nat Rev Cardiol; 2010 Oct; 7(10):549-50. PubMed ID: 20865027
[No Abstract] [Full Text] [Related]
35. Prospective pilot trial of PerMIT versus standard anticoagulation service management of patients initiating oral anticoagulation.
Borgman MP; Pendleton RC; McMillin GA; Reynolds KK; Vazquez S; Freeman A; Wilson A; Valdes R; Linder MW
Thromb Haemost; 2012 Sep; 108(3):561-9. PubMed ID: 22836303
[TBL] [Abstract][Full Text] [Related]
36. Pharmacogenetics of warfarin: current status and future challenges.
Wadelius M; Pirmohamed M
Pharmacogenomics J; 2007 Apr; 7(2):99-111. PubMed ID: 16983400
[TBL] [Abstract][Full Text] [Related]
37. Warfarin pharmacogenetics: does more accurate dosing benefit patients?
Eby C
Semin Thromb Hemost; 2012 Oct; 38(7):661-6. PubMed ID: 23047421
[TBL] [Abstract][Full Text] [Related]
38. Q: Should we use pharmacogenetic testing when prescribing warfarin?
Rouse M; Cristiani C; Teng KA
Cleve Clin J Med; 2013 Aug; 80(8):483-6. PubMed ID: 23908104
[No Abstract] [Full Text] [Related]
39. Understanding the pharmacogenetic approach to warfarin dosing.
Glurich I; Burmester JK; Caldwell MD
Heart Fail Rev; 2010 May; 15(3):239-48. PubMed ID: 18998206
[TBL] [Abstract][Full Text] [Related]
40. Warfarin pharmacogenetics: to genotype or not to genotype, that is the question.
Cavallari LH; Nutescu EA
Clin Pharmacol Ther; 2014 Jul; 96(1):22-4. PubMed ID: 24942399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
